当前位置: X-MOL 学术Stem Cell Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson's disease patient carrying the heterozygous p.A30P mutation in SNCA.
Stem Cell Research ( IF 0.8 ) Pub Date : 2020-08-08 , DOI: 10.1016/j.scr.2020.101951
Peter A Barbuti 1 , Bruno F R Santos 1 , Claire M Dording 1 , Gérald Cruciani 2 , François Massart 2 , Andreas Hummel 3 , Rejko Krüger 4
Affiliation  

Dermal fibroblasts from a patient carrying a heterozygous c.88G > C mutation in the SNCA gene that encodes alpha-synuclein were reprogrammed to pluripotency by retroviruses. This pathogenic mutation generates the p.A30P form of the alpha-synuclein protein leading to autosomal dominantly inherited Parkinson’s disease (PD). Two clonal iPS cell lines were generated (A30P-3 and A30P-4) and characterised by validating the silencing of viral transgenes, the expression of endogenous pluripotency genes, directed differentiation into three germ layers in-vitro and a stable molecular genotype. These iPSC lines will serve as a valuable resource in determining the role of the p.A30P SNCA mutation in PD pathogenesis.



中文翻译:

由帕金森氏病患者在SNCA中携带杂合的p.A30P突变产生两种iPS细胞系(HIHDNDi001-A和HIHDNDi001-B)。

将来自编码α-突触核蛋白的SNCA基因中杂合的c.88G> C突变的患者的皮肤成纤维细胞通过逆转录病毒重新编程为多能性。这种致病性突变产生α-突触核蛋白的p.A30P形式,导致常染色体显性遗传的帕金森氏病(PD)。产生了两个克隆的iPS细胞系(A30P-3和A30P-4),其特征在于验证病毒转基因的沉默,内源多能性基因的表达,体外定向分化为三个胚层和稳定的分子基因型。这些iPSC品系将成为确定p.A30P SNCA突变在PD发病机理中的重要资源。

更新日期:2020-08-08
down
wechat
bug